Le Lézard
Classified in: Health, Covid-19 virus
Subjects: NPT, TRI, AVO

1Day Sooner Petition To Prepare COVID-19 Human Challenge Trial Facilities Gains Support Of Lord, Nobel Laureate, Oxford Professor Of Medical Ethics


STAFFORDSHIRE, United Kingdom, Sept. 29, 2020 /PRNewswire/ -- A petition calling on the UK government to prepare a Challenge Study Center capable of housing 100-200 volunteers for a potential COVID-19 human challenge trial has gained the support of prominent British intellectuals including Lord Ara Darzi, Nobel Laureate Sir Richard Roberts, and Director of Medical Ethics at Oxford Uehiro Centre for Practical Ethics Dominic Wilkinson.

"Over 2,500 Britons have volunteered for a potential COVID-19 human challenge trial," said Josh Morrison, Executive Director of 1Day Sooner. "This is the first formal UK petition in support of challenge studies, and it represents a remarkable coming-together of vaccine volunteers and scientists. We hope that researchers embrace the altruism of these brave volunteers."

Lord Ara Darzi, Director of the Institute of Global Health Innovation at Imperial College London and petition signatory, said that "COVID-19 human challenge trials can quickly tell us which vaccines work, allowing vaccine developers to optimize manufacture and distribution accordingly. This is critical if we want to ensure that vaccines are accessible to all eight billion people around the world. Challenge trials can also tell researchers indispensable information about COVID-19, such as correlates of protection and early stage pathogenesis, that have wide applicability to the development of vaccines and treatments."

Dominic Wilkinson, Director of Medical Ethics at the Oxford Uehiro Centre for Practical Ethics and petition signatory, added that "it is abundantly clear that there is an ethical imperative to plan and conduct challenge trials."

To connect with a British 1Day Sooner volunteer and/or 1Day Sooner team member, please email [email protected]

Contact: Abie Rohrig, [email protected] 


These press releases may also interest you

at 18:50
Getting specialty medications into...

at 18:30
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

at 18:23
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

at 17:55
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

at 17:20
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...

at 17:00
StateHouse Holdings Inc. ("StateHouse" or the "Company") , a California-focused, vertically integrated cannabis company, today announced further to its press release dated April 15, 2024, that the Ontario Securities Commission (the "OSC") has denied...



News published on and distributed by: